Эутирокс

Quick links to important sections

Эутирокс

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Эутирокс

What is Euthyrox?

Euthyrox is a synthetic thyroid hormone medication used to treat conditions associated with an underactive thyroid gland. It contains the active substance levothyroxine sodium, which is chemically identical to thyroxine (T4), the primary hormone naturally produced and secreted by the human thyroid gland.

Therapeutic Purpose

The medication is designed to replace or supplement the natural hormone when the body cannot produce sufficient amounts on its own. By restoring thyroid hormone levels to a normal range, it helps maintain the body's metabolic processes, energy levels, and overall physiological balance.

Mechanism of Action

Once ingested, the synthetic levothyroxine in Euthyrox acts as a prohormone. It is converted by the body’s tissues into triiodothyronine (T3), the active form of the hormone. This process regulates how the body uses energy and influences various functions, including:

  • Metabolic Rate: Controlling the speed at which cells perform their functions.
  • Growth and Development: Supporting normal physical and neurological growth.
  • Organ Function: Maintaining the proper functioning of the heart, muscles, and digestive system.

Clinical Applications

Euthyrox is primarily utilized in the following clinical contexts:

  • Hypothyroidism: Managing various forms of thyroid deficiency, whether the condition is present from birth or develops later in life.
  • Goiter Management: Reducing the size of a non-toxic benign goiter or preventing its recurrence after surgical removal.
  • Hormone Suppression Therapy: Managing specific thyroid conditions where suppressing the secretion of thyroid-stimulating hormone (TSH) is necessary.

What side effects are possible with Эутирокс?

Possible side effects and safety information

The safety profile of levothyroxine sodium (Эутирокс) is primarily characterized by adverse reactions that manifest as symptoms of hyperthyroidism or therapeutic overdosage, reflecting an overly rapid increase in the body's metabolism, as documented in regulatory labeling.


Officially Documented Adverse Reactions

The officially listed adverse reactions are grouped by affected physiological systems:

  • Cardiovascular System: Palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, angina pectoris, myocardial infarction, and cardiac arrest.
  • Nervous System: Headache, nervousness, anxiety, irritability, emotional lability, insomnia, and tremors.
  • General/Metabolic: Fatigue, increased appetite, weight loss, heat intolerance, fever, and excessive sweating.
  • Gastrointestinal: Diarrhea, vomiting, and abdominal cramps.

Seizures have been reported rarely in association with the initiation of therapy. In children, partial hair loss may occur in the first few months of treatment, but this effect is generally transient.


Serious Safety Considerations

Serious risks are primarily cardiac. Overtreatment may cause arrhythmias, myocardial ischemia, and worsening of congestive heart failure, particularly in the elderly and those with underlying cardiac disease. Initiation of therapy is contraindicated in patients with uncorrected adrenal insufficiency, as it may precipitate an acute adrenal crisis.

For postmenopausal women, long-term over-replacement is associated with a risk of decreased bone mineral density (osteoporosis). The label also notes that risk of atrial fibrillation and fractures in older adults is associated with long-term TSH suppression.

Overdose and Emergency Response

The official regulatory documents state that overdosage of Levothyroxine (Эутирокс) results in clinical signs and symptoms consistent with hyperthyroidism.

Documented Overdose Manifestations

The reported manifestations of toxicity include effects on multiple physiological systems, such as tachycardia, palpitations, and increased blood pressure (Cardiovascular); tremors, nervousness, and insomnia (CNS); and physical effects like fever, heat intolerance, and weight loss.

Severe Outcomes and Emergency Action

Larger doses may produce serious or even life-threatening manifestations of toxicity. The most critical outcomes officially documented include cardiac arrest, myocardial infarction (heart attack), and severe arrhythmias. This risk of severe toxicity is noted to be particularly increased in elderly patients and those with underlying cardiovascular disease.

Due to the documented severity of these risks, any suspected overdose requires that immediate medical attention be sought. Treatment for overdosage is defined as symptomatic and supportive. Management procedures documented in regulatory guidance may involve controlling specific symptoms, such as the use of beta-blockers for cardiac effects, and utilizing methods like gastric lavage or activated charcoal to decrease drug absorption in cases of acute massive overdosage.

Therapeutic Uses of Эутирокс

Эутирокс (Levothyroxine) is an essential prescription medication commonly used to address conditions caused by an underactive thyroid gland. It serves as replacement therapy for primary, secondary, and tertiary hypothyroidism.


Therapeutic Uses and Benefits

The medication is widely considered a fundamental therapeutic option for hypothyroidism, a condition where the body has a systemic hormone deficiency. This is relevant in clinical settings marked by temporary physiological imbalance, such as following surgical thyroid removal, after radioiodine therapy, or in autoimmune conditions like Hashimoto’s disease.

Эутирокс is used for managing symptom clusters that create noticeable physiological strain and interfere with daily functioning, including persistent fatigue, unexplained weight gain, and severe cold intolerance.

It is applied across domains where additional symptomatic support is needed to assist in achieving a stable state.

This supportive relief helps patients cope more steadily with symptom fluctuations, contributing to improved day-to-day comfort and assisting with maintaining functional stability. Beyond general replacement, it is also commonly used in the long-term management of certain thyroid cancers and contributes to supportive development for infants and pregnant individuals.

Quick Fact: Relief for Systemic Imbalance
Symptom Category: Systemic Imbalance
Primary Indication: Hypothyroidism
Key Benefit: Supports functional stability

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Eligibility for Levothyroxine (Эутирокс) is defined by official regulatory documents, strictly outlining the populations permitted or prohibited from use.


Populations for Whom Use is Contraindicated

The medicine must not be used in patients with the following specific, untreated conditions, as stated in regulatory labels:

  • Untreated Overt Hyperthyroidism.
  • Acute Myocardial Infarction (AMI).
  • Untreated Acute Myocarditis or Pancarditis.
  • Uncorrected Adrenal Cortical Insufficiency.
  • Known Hypersensitivity to the active substance or excipients.

Populations Requiring Conditional Use

Use is permitted but restricted for certain groups, often requiring a lower initial dose and careful monitoring:

  • Geriatric Patients (Older Adults): Therapy must be initiated at a lower starting dose due to increased cardiac risk.
  • Underlying Cardiovascular Disease: Patients with conditions like coronary artery disease or hypertension must begin treatment with a reduced initial dose.

Age and Reproductive Eligibility

The medicine is eligible for use across all age groups, including pediatric patients (neonates and older children). Use is required and permitted during both pregnancy and lactation, although dose requirements frequently increase during pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Levothyroxine (the active substance in Euthyrox) is primarily structured around effects on its absorption, its metabolism, and the pharmacodynamic effects of other co-administered agents.


Documented Interaction Categories

Interaction Mechanism Interacting Product Categories (Examples) Key Constraint/Requirement
Reduced Absorption Antacids (Aluminum, Calcium), Iron and Calcium Supplements, Bile Acid Sequestrants, Sucralfate, PPIs Mandatory Spacing: Must be administered at least 4 hours apart.
Increased Metabolism Enzyme Inducers (Phenytoin, Rifampin, Carbamazepine) Monitoring Required: May necessitate an increase in Levothyroxine dose.
Altered Effect Oral Anticoagulants (e.g., Warfarin), Antidiabetic Agents, Sympathomimetics Dose Adjustment/Caution: Requires careful monitoring of Prothrombin Time (INR) or blood glucose levels.

Procedural and Contextual Constraints

Co-administration with oral anticoagulants increases their blood-thinning effects, necessitating frequent monitoring of Prothrombin Time and potential reduction of the anticoagulant's dose. For patients with diabetes, Levothyroxine may impair blood glucose control, which requires adjustment of antidiabetic medication (Insulin or oral hypoglycemics). Due to the risk of serious side effects, the concomitant use of Levothyroxine with sympathomimetics (especially those intended for appetite suppression) is generally discouraged. When initiating or discontinuing any interacting medicine, official regulatory guidance mandates immediate and close monitoring of Thyroid Stimulating Hormone (TSH) levels to ensure the stability of the Levothyroxine dose.

Mechanism of Action

Prohormone Activation and Nuclear Signaling

Эутирокс (Levothyroxine, T4) functions as a prohormone, requiring conversion to the biologically active hormone, Triiodothyronine ( T3), in peripheral tissues via deiodination. The resulting T3 then acts as a full agonist for the Thyroid Hormone Receptors ( TRs), which are ligand-activated transcription factors located in the cell nucleus. This foundational interaction initiates the molecular cascade that results in systemic physiological changes.


Metabolic and Endocrine Regulation

The T3/ TR complex modulates gene transcription, increasing the synthesis of metabolic enzymes and mitochondrial proteins. This action leads to a systemic increase in basal metabolic rate, heightened cellular oxygen consumption (calorigenesis), and accelerated catabolism of carbohydrates and lipids. Simultaneously, the circulating T4 and T3 exert a negative feedback mechanism on the pituitary gland, which reduces the secretion rate of Thyroid-Stimulating Hormone ( TSH). This regulatory action modulates the feedback loop dynamics of the hypothalamic-pituitary-thyroid axis, contributing to the stabilization of physiological activity across multiple systems.

Dosage and Administration Information

How to Use Эутирокс: Official Administration and Dosing Principles

Levothyroxine sodium (Эутирокс) therapy is centered on consistent, once-daily oral administration to maintain steady hormone levels, with a dose precisely adjusted to the individual's metabolic needs. The dosage is highly individualized and is determined by patient age, body weight, and TSH lab results.


Administration Route and Timing

The primary route is oral, taken as a tablet. The medication must be administered as a single daily dose on an empty stomach, generally 30 to 60 minutes before breakfast, to ensure maximum and consistent absorption. The injectable (intravenous) route is approved only for acute, severe conditions, such as myxedema coma, in a hospital setting.


Dosing and Adjustment Patterns

Treatment for most cases of hypothyroidism is typically life-long. The initial oral adult replacement dose is often calculated at approximately 1.6 mcg/kg/day, though patients with cardiac conditions or older adults begin with a lower dose, such as 12.5 mcg to 25 mcg daily, to avoid complications. Doses are not fixed and are subject to incremental adjustments, usually in 12.5 mcg or 25 mcg steps, every 4 to 8 weeks until the target TSH level is achieved. Full therapeutic effect of a dose change may not be observed for 4 to 6 weeks.


Specific Administration Instructions

To ensure proper absorption, oral levothyroxine must be administered at least 4 hours apart from compounds known to interfere with its uptake, such as drugs or supplements containing iron, calcium, or aluminum. For infants, the tablet may be crushed and suspended in a small amount of water for immediate delivery; the suspension must not be stored.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Эутирокс

Evidence for Replacement Therapy in Overt Hypothyroidism

Research exploring Эутирокс (levothyroxine sodium) for the treatment of overt hypothyroidism is built upon extensive clinical experience, regulatory studies, and long-term observational data. Given the established necessity of replacing deficient thyroid hormones, formal placebo-controlled randomized controlled trials (RCTs) are generally not performed. Studies have primarily applied in research contexts involving individuals with confirmed hormone deficiency, with research examining how the medication was associated with changes in Thyroid Stimulating Hormone (TSH) and Free Thyroxine (FT4) levels. Findings from these analyses describe patterns showing that administration of levothyroxine is associated with changes in these biomarker levels, moving them toward the reference range. A key area of ongoing research examines the persistent symptoms reported by a subset of patients whose TSH levels are regulated.


Evidence for TSH Suppression in Thyroid Cancer Management

The evidence base for using levothyroxine to suppress TSH levels following treatment for differentiated thyroid cancer (DTC) is derived from long-term retrospective and prospective observational cohort studies. Research examined how the continuous administration of levothyroxine, targeted at keeping TSH below certain levels, was associated with post-treatment outcomes. Studies monitored patients who had undergone thyroidectomy and research explored the association between TSH suppression and outcomes such as recurrence rates and long-term survival. Research also actively studies the appropriate target for TSH suppression in thyroid cancer management, exploring the association between TSH levels, recurrence events, and potential long-term physiological strain.


Evidence for Use in Subclinical Hypothyroidism during Pregnancy

Research has explored the use of levothyroxine in pregnant individuals diagnosed with Subclinical Hypothyroidism (SCH) using randomized controlled trials (RCTs). The primary outcomes research examined included maternal measures (such as miscarriage and preterm birth rates) and the long-term neurodevelopmental status of the child. Findings were mixed across high-quality RCTs, with some major research indicating that treatment with levothyroxine did not show a difference from placebo in outcomes related to the child’s long-term neurodevelopmental scores. The data for certain groups remain insufficient, and certainty remains low regarding the potential benefit of treatment for all cases of SCH in pregnancy.

Key Studies & References

  1. Thyroid cancer: assessment and management - NICE Guideline NG230 (TSH Suppression)
  2. Levothyroxine - StatPearls - NCBI Bookshelf (Review on Hypothyroidism, Dosing, and Long-Term Effects)

Frequently Asked Questions (FAQ)

Common questions about Эутирокс (FAQ)


Q: If I miss a dose of Эутирокс, what information is provided in the official instructions?

Official patient information generally suggests taking the missed dose as soon as it is remembered. However, if it is almost time for your next scheduled dose, it is generally recommended to skip the missed dose entirely. Regulatory warnings caution against taking two doses at the same time to compensate for a missed one.


Q: What should I do if I accidentally take too much Эутирокс?

According to regulatory documents, an overdosage can lead to symptoms similar to hyperthyroidism (overactive thyroid), which may include heart palpitations or tremors. As symptoms may not appear for several days, official guidance describes that contacting a doctor or a poison control center is the recommended step if an overdose is suspected.


Q: Are there any known severe allergic reactions associated with Эутирокс?

Regulatory documents indicate that cases of hypersensitivity reactions have been reported with levothyroxine, the active substance in Эутирокс. These can include severe symptoms like angioedema (swelling of the face, throat, or tongue). If signs of a suspected allergic reaction occur, official information advises discontinuing the medication and seeking appropriate medical attention.


Q: Can people with certain mental health conditions use Эутирокс?

Official warnings state that caution is recommended for patients with a history of epilepsy due to a potential risk of seizures upon initiating treatment. Patients should be monitored, and their physician should be made aware of the patient's full medical history before starting treatment.


Q: What is the difference between Эутирокс and L-Thyroxine (levothyroxine) tablets?

Эутирокс and L-Thyroxine are different product names for the same active substance: levothyroxine sodium. While regulatory agencies require thyroid hormone products to demonstrate bioequivalence (meaning they work the same way), consistency is important due to the narrow therapeutic range. Official guidance notes that TSH levels are often monitored if a patient switches between different formulations or brands.


Q: Is Эутирокс the same as other thyroid hormone medications?

Эутирокс contains synthetic T4 (thyroxine) and functions as a prohormone. This synthetic T4 is chemically identical to the hormone naturally produced by the thyroid gland. Some other thyroid hormone medications may contain T3 or a combination of T4 and T3.


Q: How long does it usually take to feel the effects of Эутирокс?

Levothyroxine has a relatively long half-life, meaning it stays in the body for a long time. Because of this, the full therapeutic effect of any dose adjustment is typically not reached for 4 to 6 weeks. Dosage adjustments are determined based on regular blood tests and how the patient responds to treatment.


Q: Is it possible to have long-term side effects from taking Эутирокс?

When taken at the correct dose, levothyroxine is intended for life-long use. However, if the dose is higher than required, it leads to symptoms of hyperthyroidism. Official warnings state that long-term over-replacement has been associated with a risk of certain health conditions, such as decreased bone mineral density, particularly in older individuals.


Q: Is it necessary to take Эутирокс at the same time every day?

Official administration information emphasizes that levothyroxine is taken as a single daily dose and consistently with respect to time of day and its relationship to meals. Consistent timing is noted in official documentation as important for maintaining stable blood hormone levels.


Q: Why are regular blood tests needed when taking Эутирокс?

Regulatory information explains that the dose of Эутирокс must be highly personalized. Therefore, regular monitoring of the Thyroid-Stimulating Hormone (TSH) level in the blood is conducted to ensure the dosage contributes to maintaining a stable hormonal state.


Q: What is the official safety classification of Эутирокс for pregnancy?

Official labeling states that treatment with levothyroxine is intended to be continued throughout pregnancy. Thyroid hormone requirements frequently increase during this time, so regular TSH monitoring is necessary to ensure the correct dose is maintained for both maternal and fetal health.


Q: Can I crush or split Эутирокс tablets if I have trouble swallowing?

Official patient information generally allows the tablets to be crushed and suspended in a small amount of water for patients, such as infants, who cannot swallow the whole tablet. If crushed, the resulting suspension is described as needing immediate administration and should not be stored.


Q: What official research evidence is available regarding the long-term use of Эутирокс?

Regulatory documents indicate that levothyroxine is approved as a replacement therapy for hypothyroidism, a condition that typically requires life-long treatment. The treatment goal is to maintain normal hormone levels long-term.


Q: Why do official documents state that Эутирокс should be taken in the morning?

The recommendation to take the medication, often in the morning, is tied to the need for it to be taken on an empty stomach. Taking it 30 to 60 minutes before breakfast ensures that food does not interfere with the proper and consistent absorption of the medication.


Q: Do older studies suggest any unique concerns for women taking Эутирокс?

Official information notes that estrogen-containing birth control pills or hormone replacement therapy can affect a woman's requirement for thyroid hormone. Monitoring and dose adjustments are often conducted when starting or stopping these medications to maintain stable hormone levels.


Q: What official information is available on children taking Эутирокс long-term?

The drug is indicated and often required for life-long replacement therapy in children with hypothyroidism. Official guidelines emphasize that dosage is carefully and regularly adjusted based on TSH and T4 levels to support normal physical growth and cognitive development.


Q: Are there any foods or drinks that should be avoided when taking Эутирокс?

Official regulatory information notes that certain substances, including foods like soy products and drinks such as coffee, can potentially interfere with the drug's absorption. Official information advises administering the drug on an empty stomach and noting that interacting substances should be taken at least four hours apart.


Q: How does Эутирокс interact with birth control pills?

Estrogen-containing birth control pills are documented to increase the body’s requirement for thyroid hormone. According to official drug interaction information, a patient's dose of levothyroxine may need to be monitored and adjusted when starting or stopping these medications to maintain stable hormone levels.


Q: Can pain relievers like ibuprofen or aspirin interact with Эутирокс?

High doses of aspirin and other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) can be associated with an effect on how levothyroxine is carried in the bloodstream. Due to this potential interaction, regulatory information indicates that TSH monitoring may be necessary when starting or stopping high-dose therapy with these pain relievers.


Q: Is it true that the effects of Эутирокс can change if I switch brands?

Because of the precise nature of thyroid hormone replacement, even minor changes in the way different brand-name formulations are manufactured can affect absorption. Regulatory agencies advise that if a switch in brand or formulation occurs, TSH levels should be re-monitored to ensure the dose remains correct.


Q: Does Эутирокс need to be stopped before surgery?

In most cases, levothyroxine treatment is continued as usual before surgery. Patients with existing heart conditions should be monitored closely during the procedure. Due to the drug's long half-life, a short interruption in oral administration generally does not cause concern, but the doctor should always be informed.


Q: What is congenital hypothyroidism, and how is it related to Эутирокс use in infants?

Congenital hypothyroidism is an underactive thyroid that is present from birth. Levothyroxine is an indicated replacement therapy for infants and children with this condition, as treatment is necessary to ensure normal physical and intellectual development.


Q: Does taking Эутирокс interact with cholesterol-lowering drugs?

Yes, some types of cholesterol-lowering drugs, specifically bile acid sequestrants (such as cholestyramine), can significantly reduce the absorption of levothyroxine. Official interaction guidance recommends that these medications be taken at least four hours apart from Эутирокс to avoid reduced absorption.


Q: How quickly does the active substance in Эутирокс enter the bloodstream?

Pharmacokinetic data from regulatory documents indicate that the time to reach the maximum plasma concentration of levothyroxine after taking an oral dose is approximately 2 to 3 hours. However, full therapeutic effect is not seen for several weeks.


Q: What is the half-life of levothyroxine, the substance in Эутирокс?

The half-life (the time it takes for half of the drug to be eliminated from the body) is approximately 6 to 7 days in patients with normal thyroid function. This long half-life is why the medication is effective as a convenient once-daily dose.


Q: Are there specific guidelines for patients with kidney or liver issues who take Эутирокс?

Official labeling does not provide specific, adjusted dosing guidelines solely for kidney or liver impairment. The dosage is primarily guided by TSH levels. Older patients or those with existing cardiovascular disease often require a lower starting dose, which may be a factor in some patients with co-existing conditions.


Q: Does Эутирокс affect the results of other lab tests besides thyroid hormones?

Yes, official labeling for levothyroxine indicates that it can interfere with the results of certain laboratory tests. These include tests for substances such as cortisol and may affect blood clotting measures, requiring careful interpretation of results by a doctor.

How should Эутирокс be stored and disposed of?

How to Store and Dispose of Эутирокс?

Regulatory guidelines strictly define the storage and disposal of Эутирокс (Levothyroxine sodium) to protect its stability.

Official Storage Requirements

Requirement Constraint
Temperature Range Store at Controlled Room Temperature (20 C–25 C), with excursions permitted up to 30 C (depending on the region).
Protection Keep the tablets in their original, tightly closed container and protect them from heat, moisture, and light.
Child Safety The medicine must be kept out of the sight and reach of children.
Tablet Stability If the tablet is crushed to make a suspension, it must be used immediately and not stored.

Official Disposal Requirements

Unused or expired Эутирокс should be disposed of in accordance with local, regional, and national regulations. Do not flush the medicine down the toilet or pour it into the sink. Disposal is intended to avoid release to the environment, and the preferred method is via an approved medicine take-back program or specialized waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Эутирокс found in:

A-Z Index: